Search

Dr. Holland was a tireless advocate for supporting the emotional and psychological needs of people with cancer. She also made huge strides in reducing the stigma surrounding the disease.

Two of MSK's top brain experts reflect on how they care for people and recent advances in treatment.

Meet Christine Iacobuzio-Donahue, a physician-scientist who studies cancer metastasis and is collaborating on genetics research with scientists at the American Museum of Natural History.

Scientists at Memorial Sloan Kettering are learning how to turn cancer’s appetite against itself.

Find out how regular screenings with CT scans can help many people who smoke.

The lack of participation in clinical research may be the Achilles heel facing today’s cancer community. According to a new survey of more than 1,500 consumers and nearly 600 physicians conducted on behalf of MSK, only 35 percent of Americans indicated that they were “likely” to enroll in a clinical trial. For more information or to schedule an interview, please contact [email protected].

New MSK research helped develop a machine-learning tool to help find cancer cells that remain after surgery; led to FDA approval for CAR T cell therapy against mantle cell lymphoma; tested a liquid biopsy approach that shows promise in detecting lung cancer; found checkpoint inhibitors were effective against endometrial and ovarian cancers with DNA-repair deficiency; and shed new light on mTOR's role in metabolic enzyme degradation.